The 53 Member States of the WHO European Region have unanimously adopted their first Roadmap for Action on Artificial Intelligence in Health, establishing a common policy direction for integrating AI into healthcare systems over 2026–2033.
Approved at the 76th session of the WHO Regional Committee for Europe, the roadmap covers a region extending beyond the European Union to include countries in Central Asia. Its ambition is to support health professionals and improve care while building the conditions for safe, effective and equitable use of AI.
From shared principles to implementation
The roadmap brings together four connected priorities:
- Governance and leadership: connecting AI with national health priorities, clear responsibilities and sustained investment.
- Ethical, regulatory and legal frameworks: putting safeguards and oversight in place throughout the life of AI applications.
- Data and digital infrastructure: improving data quality, interoperability, secure access and cybersecurity.
- Capacity building, implementation support and learning: developing workforce skills and evaluating AI in real healthcare settings.
The approach draws on WHO’s 2025 assessment of AI readiness, which received responses from 50 of the region’s 53 Member States. An accompanying implementation guide is intended to help countries translate the roadmap into action at different levels of digital maturity.
Implications for research and healthcare innovation
For hospitals, universities, medical research organisations and technology developers, the roadmap provides a policy reference for work on AI-supported diagnostics, clinical decision-making, digital health and health-data infrastructure.
A practical implication for research teams and European consortia is the need to plan beyond technical performance. Clinical validation, data stewardship, staff skills and integration into healthcare workflows all influence whether an application can be adopted and used effectively. These considerations can help shape project objectives, evaluation plans and pathways to uptake.
The emphasis on interoperability and institutional capacity is also relevant to cross-border collaboration. Partners may share an AI research objective while working with different data environments, governance arrangements and levels of readiness. Identifying those differences early can make implementation plans more credible.
A regional policy reference
WHO presents the roadmap as aligned with existing European and international instruments, including the EU AI Act, the European Health Data Space and the GDPR. For organisations developing healthcare AI, this connects the regional vision with the regulatory and data-governance context in which applications will operate.
WHO regional roadmap formally adopted for 2026–2033. It is a policy framework, not binding EU legislation. Adoption of the roadmap does not itself establish regulatory compliance or clinical validation for any AI application.